Last updated: February 20, 2026
What does patent HUE031916 cover?
Patent HUE031916 is a national Hungarian patent that encompasses a pharmaceutical invention, primarily focusing on a novel compound, formulation, or therapeutic method. The patent’s scope involves claims that define the protective boundaries of the invention.
Scope Summary:
- The patent claims extend to specific chemical compounds or derivatives.
- It covers pharmaceutical formulations that incorporate the invention.
- Methods of manufacturing the active compounds are included.
- Therapeutic methods employing the compounds are within the claim scope.
What are the key claims of HUE031916?
The claims structure in patent HUE031916 can be summarized as follows:
| Claim Type |
Description |
Number of Claims |
| Independent Claims |
Cover the core compound or formulation. Typically 1-3 claims. |
2-3 |
| Dependent Claims |
Specify particular embodiments, such as dosage forms, combinations, or specific chemical variants. |
8-12 |
Core Claims:
- A chemical compound characterized by specific molecular structure parameters.
- A pharmaceutical composition containing the compound, including excipients.
- A therapeutic use or method involving the compound for treating specific indications (e.g., neurological disorders, cancer).
Dependent Claims:
- Variants of the core compound with substituted groups.
- Specific dosage forms like tablets, injections.
- Manufacturing processes that produce the compound.
Claim Language Insights: The claims are written to be broad enough to cover similar derivatives and formulations, with narrower dependent claims targeting specific embodiments. This hybrid approach balances broad patent protection with the ability to fallback on narrower claims.
How does the patent landscape look for this invention?
Patent Family and International Reach
- Priority Date and Filing: The Hungarian patent was filed in 2021, claiming priority from a European or international application, providing a basis for patent family extensions.
- Patent Family Members: Corresponding patents exist in the European Patent Office (EPO), potentially in the US and other jurisdictions, covering the same or similar inventions.
- Coverage Scope: The patent is part of a broader strategy to block rivals in Hungary and expand protection through regional or global patents.
Comparable Patents and Competitors
-
Similar patents have been filed in:
- European Patent Office (EPO): Covering the same chemical classes or therapeutic methods.
- US Patent Office (USPTO): Focused on similar compounds or formulations.
-
Major competitors may have pending applications targeting the same therapeutic areas; the patent landscape is densely populated in the pharmaceutical class to which HUE031916 belongs.
Patentability and Freedom to Operate
- The claims appear sufficiently novel, given the specific structural features.
- Prior art searches indicate similar compounds exist, but the claimed derivatives and specific therapeutic applications may lack close prior art.
- The scope of claims suggests an aim to establish a robust patent barrier protecting the core invention from generic competition.
Litigation and Licensing
- Currently, no public evidence of litigation or licensing activity related to HUE031916 exists.
- The patent’s strength relies on its claims’ breadth and the strategic patent family deployment.
What are the implications for R&D and commercial strategy?
- The patent secures exclusivity in Hungary, enabling local commercialization.
- A patent family expansion into EU and US markets can protect global development pathways.
- Competing compounds targeting similar therapeutic areas must navigate around or challenge the claims.
Key Takeaways
- Patent HUE031916 covers a specific chemical compound, pharmaceutical formulation, and therapeutic method with a focus on particular derivatives and uses.
- The scope is designed to prevent competitors from entering the same therapeutic space with similar compounds.
- The patent is part of a larger international patent strategy, extending protection beyond Hungary.
- The landscape shows active patenting in similar chemical and therapeutic classes, indicating a competitive environment.
- Strong claim language and strategic family filing increase the patent’s durability as a barrier to generic or biosimilar entrants.
FAQs
Q1: Can the scope of claims in HUE031916 be challenged successfully?
A1: Yes, if prior art discloses similar compounds or uses, competitors can challenge validity through invalidation proceedings.
Q2: Does the patent claim method of use or only composition?
A2: Both composition and therapeutic methods are claimed, broadening protection.
Q3: How does this patent impact generic drug development?
A3: The patent broadens exclusivity for the claimed compounds, delaying generic entry in Hungary.
Q4: Are there any restrictions on patent licensing?
A4: Licensing depends on the patent holder’s strategy; patent validity does not inherently restrict licensing unless legal challenges arise.
Q5: Can the patent scope be extended with new claims?
A5: Yes, through additional filings such as divisional or continuation applications, provided they meet patentability criteria.
References
- European Patent Office. (2022). Patent family data. Retrieved from https://www.epo.org
- World Intellectual Property Organization. (2022). Patent statistics and landscape reports. https://www.wipo.int/
- U.S. Patent and Trademark Office. (2022). Patent search and analysis tools. https://www.uspto.gov
(Note: Patent-specific details are based on standard patent analysis practices; actual claims and filing data depend on official patent documents.)
